These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30165451)

  • 21. Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania.
    Mosha F; Urassa W; Aboud S; Lyamuya E; Sandstrom E; Bredell H; Williamson C
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):377-82. PubMed ID: 20954839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.
    Murillo W; Lorenzana de Rivera I; Albert J; Guardado ME; Nieto AI; Paz-Bailey G
    J Med Virol; 2012 Oct; 84(10):1514-21. PubMed ID: 22930496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia.
    Budayanti NS; Merati TP; Bela B; Mahardika GN
    Curr HIV Res; 2018; 16(5):374-382. PubMed ID: 30714528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment HIV drug resistance in adults initiating antiretroviral therapy in China, 2017.
    Kang RH; Liang SJ; Ma YL; Liang S; Xiao L; Zhang XH; Lu HY; Xu XQ; Luo SB; Sun XG; Chen L; He JM; Wu GH; Liao LJ; Xing H; Shao YM; Ruan YH
    Infect Dis Poverty; 2020 May; 9(1):54. PubMed ID: 32448388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in transmitted HIV drug resistance among persons undergoing genotypic resistance testing in Ontario, Canada, 2002-09.
    Burchell AN; Bayoumi AM; Rourke SB; Major C; Gardner S; Sandstrom P; Rachlis A; Taylor D; Mazzulli T; Fisher M; Brooks J;
    J Antimicrob Chemother; 2012 Nov; 67(11):2755-65. PubMed ID: 22833637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Diversity and Drug Resistance Among Antiretroviral Treatment-Failed Individuals from 2010 to 2012 in Honghe, China.
    Yang C; Yang S; Li J; Yang B; Liu J; Li H; Bian Z
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):822-9. PubMed ID: 25919896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.
    Lunar MM; Židovec Lepej S; Tomažič J; Vovko TD; Pečavar B; Turel G; Maver M; Poljak M
    PLoS One; 2018; 13(4):e0196670. PubMed ID: 29698470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV transmitted drug resistance in adult and pediatric populations in Panama.
    Castillo J; Arteaga G; Mendoza Y; Martínez AA; Samaniego R; Estripeaut D; Page KR; Smith RE; Sosa N; Pascale JM
    Rev Panam Salud Publica; 2011 Dec; 30(6):649-56. PubMed ID: 22358417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013.
    McCluskey SM; Lee GQ; Kamelian K; Kembabazi A; Musinguzi N; Bwana MB; Muzoora C; Haberer JE; Hunt PW; Martin JN; Boum Y; Bangsberg DR; Harrigan PR; Siedner MJ
    AIDS Patient Care STDS; 2018 Jul; 32(7):257-264. PubMed ID: 29985647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
    Rossetti B; Di Giambenedetto S; Torti C; Postorino MC; Punzi G; Saladini F; Gennari W; Borghi V; Monno L; Pignataro AR; Polilli E; Colafigli M; Poggi A; Tini S; Zazzi M; De Luca A;
    HIV Med; 2018 Oct; 19(9):619-628. PubMed ID: 29932313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children.
    Boerma RS; Boender TS; Sigaloff KC; Rinke de Wit TF; van Hensbroek MB; Ndembi N; Adeyemo T; Temiye EO; Osibogun A; Ondoa P; Calis JC; Akanmu AS
    J Int AIDS Soc; 2016; 19(1):21140. PubMed ID: 27836020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype.
    Parczewski M; Leszczyszyn-Pynka M; Witak-Jędra M; Maciejewska K; Rymer W; Szymczak A; Szetela B; Gąsiorowski J; Bociąga-Jasik M; Skwara P; Garlicki A; Grzeszczuk A; Rogalska M; Jankowska M; Lemańska M; Hlebowicz M; Barałkiewicz G; Mozer-Lisewska I; Mazurek R; Lojewski W; Grąbczewska E; Olczak A; Jabłonowska E; Clark J; Urbańska A
    J Antimicrob Chemother; 2015 Jan; 70(1):233-42. PubMed ID: 25248322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transmitted drug resistance among HIV infected men who have sex with men in Tianjin, 2014-2017].
    Zheng MN; Ning TL; Zhou N; Zhao X; Li L; Zhu JJ; Cheng SH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):619-624. PubMed ID: 29860805
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
    J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China.
    Zhang J; Guo Z; Yang J; Pan X; Jiang J; Ding X; Zhang W; Xia Y; Xu Y; Huang J
    J Med Virol; 2015 Oct; 87(10):1668-76. PubMed ID: 25899877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.
    Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L;
    PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.
    Boerma RS; Sigaloff KC; Akanmu AS; Inzaule S; Boele van Hensbroek M; Rinke de Wit TF; Calis JC
    J Antimicrob Chemother; 2017 Feb; 72(2):365-371. PubMed ID: 27999070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015.
    Ghafari S; Memarnejadian A; Samarbaf-Zadeh A; Mostafavi E; Makvandi M; Salmanzadeh S; Ghadiri A; Jordan MR; Mousavi E; Jahanbakhsh F; Azadmanesh K
    Arch Virol; 2017 Sep; 162(9):2737-2745. PubMed ID: 28589513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of pre-treatment HIV drug resistance in Papua New Guinea: findings from the first nationally representative pre-treatment HIV drug resistance study.
    Gare J; Toto B; Pokeya P; Le LV; Dala N; Lote N; John B; Yamba A; Soli K; DeVos J; Paulin H; Wagar N; Zheng DP; Nishijima T; Boas P; Kelly-Hanku A; Gurung A
    BMC Infect Dis; 2022 Mar; 22(1):266. PubMed ID: 35305571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.